Myeloid-derived-suppressor cells as regulators of the immune system

Gabrilovich, Dmitry I., Nagaraj, Srinivas·2009·Nature Reviews Immunology

Cited by (1,052)

Items 901–1,000 of 1,052

  1. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses
    Nikolaus Peter Rieber, Christian Gille, Natascha Köstlin, Iris Schäfer, Bärbel Spring, M Ost, Helen Spieles, Hellen Kugel, Matthias Manuel Pfeiffer, Vanessa Heininger et al. · 2013 · Clinical & Experimental Immunology
  2. Balancing the innate immune system in tumor development
    C. Hagerling, A. Casbon, Z. Werb · 2014 · Trends in Cell Biology
  3. Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells
    Laura M. Hix, John Karavitis, Mohammad Wasim Khan, Yihui H. Shi, Khashayarsha Khazaie, Ming Zhang · 2013 · Journal of Biological Chemistry
  4. Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes
    Shigehisa Kitano, Michael Andrew Postow, Carly G.K. Ziegler, Deborah Kuk, Katherine S. Panageas, Czrina A. Cortez, Teresa S. Rasalan, Matthew J. Adamow, Jianda D. Yuan, Phillip Wong et al. · 2014 · Cancer Immunology Research
  5. Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
    Javier Rodríguez‐Ubreva, Francesc Català‐Moll, Nataša Obermajer, Damiana Álvarez‐Errico, Ricardo N. Ramírez, Roser Vento‐Tormo, Gema Moreno‐Bueno, Robert P. Edwards, Ali Mortazavi, Paweł Kaliński et al. · 2017 · Cell Reports
  6. Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
    Gianfranco Mattia, Rossella Puglisi, Barbara Ascione, Walter Malorni, Alessandra Carè, Paola Matarrese · 2018 · Cell Death and Disease
  7. Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
    Runda Wu, Wei Gao, Yao Kang, Junbo Ge · 2019 · Frontiers in Immunology
  8. STAT3: A Target to Enhance Antitumor Immune Response
    Heehyoung Lee, Sumanta Kumar Pal, Karen L. Reckamp, Robert A. Figlin, Hua Yu · 2010 · Current topics in microbiology and immunology
  9. β‐Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid‐derived suppressor cells
    Jie Tian, Jie Ma, Ke Ma, Hongye Guo, Samuel Essien Baidoo, Yue Zhang, Jun Yan, Liwei Lu, Huaxi Xu, Shengjun Wang · 2013 · European Journal of Immunology
  10. In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site
    Jessica M. Haverkamp, Scott A. Crist, Bennett D. Elzey, Cansu Cimen Bozkus, Timothy L. Ratliff · 2011 · European Journal of Immunology
  11. Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma
    Saleh Rachidi, Kristin Wallace, John M. Wrangle, Terry A. Day, Anthony J. Alberg, Zihai Li · 2015 · Head & Neck
  12. Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
    Simon Gebremeskel, Brent Johnston · 2015 · Oncotarget
  13. Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
    Astrid Olsnes Kittang, Shahram Y. Kordasti, Kristoffer Evebø Sand, Benedetta Costantini, Anne Marijn Kramer, Pilar Perez Abellan, Thomas Seidl, Kristin Paulsen Rye, Karen Marie Hagen, Austin Gladston Kulasekararaj et al. · 2015 · OncoImmunology
  14. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation
    Yuli Lin, Xuguang Yang, Wen Liu, B. Li, W Yin, Ying–Hong Shi, Rui He · 2017 · Oncogene
  15. Profiling Prostate Cancer Therapeutic Resistance
    Cameron Alexander Wade, Natasha Kyprianou · 2018 · International Journal of Molecular Sciences
  16. Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
    Peng-Fei Wang, Siying Song, Tingjian Wang, Wenjun Ji, Shouwei Li, Ning Liu, Changxiang Yan · 2018 · OncoImmunology
  17. Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
    Romain‐David Seban, John S. Nemer, Aurélien Marabelle, Randy Yeh, Éric Deutsch, Samy Ammari, Antoine Moya‐Plana, Fatima‐Zohra Mokrane, Robyn D. Gartrell, Grace G. Finkel et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
  18. CpG Oligonucleotides as Cancer Vaccine Adjuvants
    Hidekazu Shirota, Debra Tross, Dennis M. Klinman · 2015 · Vaccines
  19. A Role for Immature Myeloid Cells in Immune Senescence
    Elena Yu. Enioutina, Diana Bareyan, Raymond A. Daynes · 2010 · The Journal of Immunology
  20. Comparison of experimental mouse models of inflammatory bowel disease
    SOO YOUN OH, Kyung‐Ah Cho, Jihee Lee Kang, Kwang Ho Kim, So‐Youn Woo · 2013 · International Journal of Molecular Medicine
  21. Natural Killer Cells and Solid Tumors
    Ana Stojanovic, Adelheid Cerwenka · 2011 · Journal of Innate Immunity
  22. The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
    Yoshiro Itatani, Kenji Kawada, Susumu Inamoto, Takamasa S. Yamamoto, Ryotaro Ogawa, Makoto Mark Taketo, Yoshiharu Sakai · 2016 · International Journal of Molecular Sciences
  23. New insights into the resolution of inflammation
    Derek William Gilroy, Roel P. H. De Maeyer · 2015 · Seminars in Immunology
  24. Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation
    Hui Zhang, Shuang Wang, Yuefang Huang, Hongyue Wang, Jijun Zhao, Felicia Gaskin, Niansheng Yang, Shu Man Fu · 2015 · Clinical Immunology
  25. Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
    Taku Fujimura, Sabine Ring, Viktor Umansky, Karsten Mahnke, Alexander Enk · 2011 · Journal of Investigative Dermatology
  26. Innate immune mediators in cancer: between defense and resistance
    Pedro Berraondo, Luna Minute, Daniel Ajona, Leticia P. Corrales, Ignacio Melero, Rubén Pı́o · 2016 · Immunological Reviews
  27. Targeting tumor associated macrophages: The new challenge for nanomedicine
    Fernando Torres Andón, Elisabeth Digifico, Akihiro Maeda, Marco Erreni, Alberto Mantovani, Marı́a José Alonso, Paola Allavena · 2017 · Seminars in Immunology
  28. Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy
    Minliang Wu, Wenjun Le, Tianxiao Mei, Yuchong Wang, Bingdi Chen, Zhongmin Liu, Chunyu Xue · 2019 · International Journal of Nanomedicine
  29. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
    Alisha Holtzhausen, William P. Harris, Eric Ubil, Debra M. Hunter, Jichen Zhao, Yuewei Zhang, Dehui� Zhang, Qingyang Liu, Xiaodong Wang, Douglas K. Graham et al. · 2019 · Cancer Immunology Research
  30. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer
    Paola Marcovecchio, Graham D. Thomas, Shahram Salek‐Ardakani · 2021 · Journal for ImmunoTherapy of Cancer
  31. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
    Jiayao Ma, Lingjuan Huang, Die Hu, Shan Zeng, Ying Han, Hong Shen · 2021 · Journal of Experimental & Clinical Cancer Research
  32. Immunity and Immune Suppression in Human Ovarian Cancer
    Claudia C. Preston, Ellen L. Goode, Lynn C. Hartmann, Kimberly R. Kalli, Keith L. Knutson · 2011 · Immunotherapy
  33. Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
    Ngozi R. Monu, Alan B. Frey · 2012 · Immunological Investigations
  34. Myeloid-Derived Suppressor Cells in Bacterial Infections
    Michael Ost, Anurag Singh, Andreas Peschel, Roman Mehling, Nikolaus Peter Rieber, Dominik Hartl · 2016 · Frontiers in Cellular and Infection Microbiology
  35. Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations
    Ryan C. Augustin, Greg M. Delgoffe, Yana George Najjar · 2020 · Cancers
  36. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
    Leonid S. Metelitsa · 2010 · Clinical Immunology
  37. Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer
    Paola Cappello, Simona Rolla, Roberto Chiarle, Moitza Principe, Federica Cavallo, Giovanni Perconti, Salvatore Feo, Mirella Giovarelli, Francesco Novelli · 2013 · Gastroenterology
  38. Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
    Amy Hughes, Agnes S. M. Yong · 2017 · Frontiers in Immunology
  39. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer
    Kenji Gonda, Masahiko Shibata, Tohru Ohtake, Yoshiko Matsumoto, Kazunoshin Tachibana, Noriko Abe, Hitoshi Ohto, Kenichi Sakurai, Seiichi Takenoshita · 2017 · Oncology Letters
  40. STAT3, a master regulator of anti-tumor immune response
    Rébé, Cédric, Ghiringhelli, François · 2019 · Cancers
  41. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
    Egle Kvedaraite, Laura Hertwig, Indranil Sinha, Andrea Ponzetta, Ida Hed Myrberg, Magda Lourda, Majda Dzidic, Mira Akber, Jonas Klingström, Elin Folkesson et al. · 2021 · Proceedings of the National Academy of Sciences
  42. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
    Anna H.E. Roukens, Cilia R. Pothast, Marion H. König, Wesley Huisman, Tim J. Dalebout, Tamar Tak, Shohreh Azimi, Yvonne C. M. Kruize, Renate S. Hagedoorn, Mihaela Zlei et al. · 2021 · Nature Immunology
  43. Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
    Iraklis C. Kourtis, Sachiko Hirosue, Alexandre de Titta, Stephan Kontos, Toon Stegmann, Jeffrey A. Hubbell, Melody A. Swartz · 2013 · PLoS ONE
  44. Melanoma-induced immunosuppression and its neutralization
    Viktor Umansky, Alexandra Sevko · 2012 · Seminars in Cancer Biology
  45. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
    Giovanna Bianchi, Marta Vuerich, Patrizia Pellegatti, Danilo Marimpietri, Laura Emionite, Ilaria Marigo, Vincenzo Bronte, Francesco Di Virgilio, Vito Pistoia, Lizzia Raffaghello · 2014 · Cell Death and Disease
  46. Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease
    Nikolaus Peter Rieber, Abby Brand, Andreas Hector, Ute Graepler-Mainka, Michael Ost, Iris Schäfer, Irene Wecker, Davide Neri, Andreas Wirth, Lauren Mays et al. · 2013 · The Journal of Immunology
  47. Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors
    Javier Molina‐Cerrillo, Teresa Alonso‐Gordoa, Pablo Gajate, Enrique Grande · 2017 · Cancer Treatment Reviews
  48. Targeting myeloid cells in the tumor sustaining microenvironment
    Jonathan Schupp, Franziska K. Krebs, Niklas Zimmer, Emily R. Trzeciak, Detlef Schuppan, Andrea Tuettenberg · 2017 · Cellular Immunology
  49. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes
    Huai Liu, Ling Yin Tang, Yanxian Li, Wenji Xie, Ling Zhang, Hailin Tang, Tengfei Xiao, Hongmin Yang, Wangning Gu, Hui Wang et al. · 2024 · Molecular Cancer
  50. Myeloid-Derived Cells in Tumors: Effects of Radiation
    Ralph E. Vatner, Silvia Chiara Formenti · 2014 · Seminars in Radiation Oncology
  51. Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications.
    Zhixue Zheng, Zhaode Bu, Xijuan Liu, Lianhai Zhang, Ziyu Li, Aiwen Wu, Xiaojiang Wu, Xiaojing Cheng, Xiaofang Xing, Hong Du et al. · 2014 · Europe PMC (PubMed Central)
  52. Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
    Mengmeng Jiang, Jieying Chen, Wenwen Zhang, Rui Zhang, Yingnan Ye, Pengpeng Liu, Wenwen Yu, Feng Wei, Xiubao Ren, Jinpu Yu · 2017 · Frontiers in Immunology
  53. Anti‐ IL ‐6 receptor m A b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T ‐cell responses
    Kentaro Sumida, Daiko Wakita, Yoshinori Narita, Kazutaka Masuko, Satoshi Terada, Kazue Watanabe, Takayuki Satoh, Hidemitsu Kitamura, Takashi Nishimura · 2012 · European Journal of Immunology
  54. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells
    Kihyun Lee, Hee Yeon Won, Myung Ae Bae, Jeong‐Ho Hong, Eun Sook Hwang · 2011 · Proceedings of the National Academy of Sciences
  55. Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
    Venkatesh L. Hegde, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2011 · PLoS ONE
  56. Hepatic Stellate Cells Regulate Immune Response by Way of Induction of Myeloid Suppressor Cells in Mice Δσ
    Hong-Shiue Chou, Ching‐Chuan Hsieh, Horng-Ren Yang, Lianfu Wang, Yusuke Arakawa, Kathleen Brown, Qingyu Wu, Feng Lin, Marion G. Peters, John J. Fung et al. · 2011 · Hepatology
  57. Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
    Juan Ling Fu, Ian‐James Malm, Deepak K. K. Kadayakkara, Hy Levitsky, Drew M. Pardoll, Young Jin Kim · 2014 · Cancer Research
  58. Engineering the pre-metastatic niche
    Brian A. Aguado, Grace G. Bushnell, Shreyas S. Rao, Jacqueline Sara Jeruss, Lonnie D. Shea · 2017 · Nature Biomedical Engineering
  59. Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion
    Lee A. Albacker, Jeremy Wu, Peter G. Smith, Markus Warmuth, Philip J. Stephens, Ping Zhu, Lihua Yu, Juliann Chmielecki · 2017 · PLoS ONE
  60. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients
    Julie A. Stortz, Juan C. Mira, Steven L. Raymond, Tyler John Loftus, Tezcan Ozrazgat‐Baslanti, Zhongkai Wang, Gabriela L. Ghita, Christiaan Leeuwenburgh, Mark S. Segal, Azra Bihorac et al. · 2017 · The Journal of Trauma: Injury, Infection, and Critical Care
  61. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
    Prajna Guha, Jillian Gardell, J. Kebbeh Darpolor, Marissa Cunetta, Matthew Lima, George Miller, N. Joseph Espat, Richard Paul Junghans, Steven C. Katz · 2018 · Oncogene
  62. The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging
    Saad M. Khan, Yi Tao Chan, Xavier S. Revelo, Daniel A. Winer · 2020 · Frontiers in Endocrinology
  63. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
    Fang Wei, Dan Wang, Junyuan Wei, Niwen Tang, Le Min Tang, Fang Xiong, Can Jie Guo, Ming Zhou, Xiaoling Li, Guiyuan Li et al. · 2020 · Cellular and Molecular Life Sciences
  64. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
    Debolina Ganguly, Raghav Chandra, John D. Karalis, Martha E. Teke, Todd Anthony Aguilera, Ravikanth Maddipati, Megan Wachsmann, Dario Ghersi, Giulia Siravegna, Herbert J. Zeh et al. · 2020 · Cancers
  65. Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma
    Kazim H Narsinh, Edgar Perez, Alexander F. Haddad, Jacob S. Young, Luis Emilio Savastano, Javier E. Villanueva-Meyer, Ethan A. Winkler, John de Groot · 2024 · Current Neurology and Neuroscience Reports
  66. Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
    Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel · 2024 · Nature Reviews Clinical Oncology
  67. Myeloid‐derived suppressor cells in parasitic infections
    Jo A. Van Ginderachter, Alain Beschin, Patrick DE BAETSELIER, Geert Raes · 2010 · European Journal of Immunology
  68. Pathogenic Fungi Regulate Immunity by Inducing Neutrophilic Myeloid-Derived Suppressor Cells
    Nikolaus Peter Rieber, Anurag Singh, Hasan Halit Öz, Melanie Carevic, Maria Bouzani, Jorge Amich, Michael Ost, Zhiyong Ye, Marlene Ballbach, Iris Schäfer et al. · 2015 · Cell Host & Microbe
  69. HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment
    Stefan Hartmann, Neil E. Bhola, Jennifer Rubin Grandis · 2016 · Clinical Cancer Research
  70. Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy
    Xilong Wu, Yundi Wu, Hongbo Ye, Shuangjiang Yu, Chaoliang He, Xuesi Chen · 2017 · Journal of Controlled Release
  71. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair
    Cathelijn E.M. Aarts, Ida H. Hiemstra, Eelke P. Béguin, Arjan J. Hoogendijk, Souhailla Bouchmal, Michel van Houdt, Anton T. J. Tool, Erik P. J. Mul, Machiel H. Jansen, Hans Janssen et al. · 2019 · Blood Advances
  72. Vascular Microenvironment, Tumor Immunity and Immunotherapy
    Zachary L Lamplugh, Yi Fan · 2021 · Frontiers in Immunology
  73. CXCL8 in Tumor Biology and Its Implications for Clinical Translation
    Xingyu Xiong, Xinyang Liao, Shi Qiu, Hang Xu, Shiyu Zhang, Sheng Wang, Jianzhong Ai, Lu Yang · 2022 · Frontiers in Molecular Biosciences
  74. Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
    Vetsika, Eleni-Kyriaki, Koukos, Aristeidis, Kotsakis, Athanasios · 2019 · Cells
  75. The role of chemokines and their receptors in angiogenesis
    Friedemann Kiefer, Arndt F. Siekmann · 2011 · Cellular and Molecular Life Sciences
  76. Hypoxia-inducible factors in cancer stem cells and inflammation
    Gong Peng, Yang Liu · 2015 · Trends in Pharmacological Sciences
  77. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
    Vijay Kumar · 2012 · Purinergic Signalling
  78. Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role
    Jianping Huang, Caroline Jochéms, Tara Talaie, Austin Anderson, Alessandra Jales, Kwong Yok Tsang, Ravi Amrit Madan, James L. Gulley, Jeffrey Schlom · 2012 · Blood
  79. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
    Laura Pinton, Samantha Solito, Vera Damuzzo, Samuela Francescato, Assunta Pozzuoli, Antonio Berizzi, Simone Mocellin M. D, Carlo Riccardo Rossi, Vincenzo Bronte, Susanna Mandruzzato · 2015 · Oncotarget
  80. CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
    Hongfei Wang, Yixuan Sun, Xiuman Zhou, Chunxia Chen, Ling Jiao, Wanqiong Li, Shanshan Gou, Yanying Li, Jiangfeng Du, Guanyu Chen et al. · 2020 · Journal for ImmunoTherapy of Cancer
  81. Exercise-induced myokines and their effect on prostate cancer
    Jin‐Soo Kim, Daniel Abido Galvao, Robert Usher Newton, Elin Solomonovna Gray, Dennis R. Taaffe · 2021 · Nature Reviews Urology
  82. Cancer Immunotherapy via Dendritic Cells
    Karolina Palucka, Jacques Banchereau · 2013 · Springer eBooks
  83. Myeloid‐Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis
    Verónica Moliné-Velázquez, Henar Cuervo, Virginia Vila‐del Sol, María Cristina Ortega, Diego Clemente, Fernando de Castro · 2011 · Brain Pathology
  84. Chemotherapy and tumor microenvironment of pancreatic cancer
    Liu, Qiaofei, Liao, Quan, Zhao, Yupei · 2017 · Cancer Cell International
  85. Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
    Oana Draghiciu, Hans W. Nijman, Baukje Nynke Hoogeboom, Tjarko Meijerhof, Toos Daemen · 2015 · OncoImmunology
  86. The Role of Anti-Inflammatory Drugs in Colorectal Cancer
    Dingzhi Wang, Raymond N. DuBois · 2012 · Annual Review of Medicine
  87. Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
    Vasiliki Gkretsi, Andreas Stylianou, Panagiotis Papageorgis, Christiana Polydorou, Triantafyllos Stylianopoulos · 2015 · Frontiers in Oncology
  88. Targeting the tumour microenvironment in ovarian cancer
    Jean Marie Hansen, Robert Louis Coleman, Anil K. Sood · 2016 · European Journal of Cancer
  89. Immunotherapy in Ovarian Cancer: Are We There Yet?
    Lana Elias Kandalaft, Kunle O. Odunsi, George Coukos · 2019 · Journal of Clinical Oncology
  90. Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice
    Ruixin Sun, Hong Luo, Jingwen Su, Shengmeng Di, Min Zhou, Bizhi Shi, Yansha Sun, Guoxiu Du, Honghong Zhang, Hua Jiang et al. · 2020 · Molecular Therapy
  91. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
    Songxin Zhu, Yuming Wang, Jun Tang, Min Cao · 2022 · Frontiers in Immunology
  92. Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
    Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou, Cameron M. Messier, Patrick Hall Lizotte, Kathleen Lindahl Pfaff et al. · 2023 · Science Immunology
  93. Immunology of hepatocellular carcinoma
    Meenakshi Sachdeva · 2015 · World Journal of Hepatology
  94. IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
    Kevin M. Hart, Katelyn T. Byrne, Michael J. Molloy, Edward M. Usherwood, Brent L. Berwin · 2011 · Frontiers in Immunology
  95. Lymphatic function and immune regulation in health and disease
    Liao, Shan, Padera, Timothy P. · 2013 · Lymphatic Research and Biology
  96. Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment
    Di Liu, Cheng Chang, Ning Lü, Xing Wang, Qian Lu, Xiaojie Ren, Peng Ren, Dianyuan Zhao, Lijing Wang, Yunping Zhu et al. · 2016 · Journal of Proteome Research
  97. Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments
    Jéssica Cristina dos Santos, Leah M. Pyter · 2018 · Frontiers in Immunology
  98. The role of sodium in modulating immune cell function
    Nicola Wilck, András Balogh, Lajos Markó, Hendrik Bartolomaeus, Dominik N. Müller · 2019 · Nature Reviews Nephrology
  99. Recent developments in immunotherapy for gastrointestinal tract cancers
    Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, Wen‐Fei Li, Lin Cong, Jialin Lu, Liyang Mo, Huizhen Liu, Siyi He, Chao Yu et al. · 2024 · Journal of Hematology & Oncology
  100. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
    Dimitrios Mougiakakos, Regina Jitschin, Lena von Bahr, Isabel C. Poschke, Regina Gary, Berit Sundberg, Armin Gerbitz, Per T Ljungman, Katarina Le Blanc · 2012 · Leukemia